Abbott Laboratories

Abbott Laboratories vs. Intuitive Surgical: Which Healthcare Stock Is a Better Buy in 2026?

Intuitive Surgical is beating estimates and raising margins while its installed base keeps expanding. Abbott is executing steadily across a diversified portfolio but growing at a more measured pace.

Yahoo Finance · 01/10/2026 · lire l'article ↗

Abbott Stock And Other Healthcare Dividend Names Built For Supply Chain Shocks

Markets are back to obsessing over central bank signals, supply routes and growth downgrades, and that mix is shaking up how investors look at reliable income. When credit feels tighter and headlines keep flagging disruption risks, steady dividend cheques from global healthcare stocks can suddenly look more interesting. This piece walks through three healthcare dividend payers from our screener that appear closely exposed to the latest macro news and explains why their stories might matter to...

Yahoo Finance · 01/10/2026 · lire l'article ↗

Abbott Laboratories’ Quarterly Earnings Preview: What You Need to Know

Abbott Laboratories is set to report its third-quarter results coming month, with analysts expecting single-digit growth in earnings.

Yahoo Finance · 01/10/2026 · lire l'article ↗

Biomarkers Market Forecasts Growth from $67.95B (2026) to $112.10B by 2031, Profiling Roche, Abbott, Thermo Fisher & Qiagen

The global biomarkers market is projected to grow from USD 67.95 billion in 2026 to USD 112.10 billion by 2031, registering a 10.5% CAGR. Growth is driven by precision medicine, companion diagnostics, AI, bioinformatics, digital pathology and multi-omics technologies. Predictive biomarkers led the efficacy segment in 2025, while immunoassays held the largest technology share. Asia Pacific is forecast to be the fastest-growing region. Key players include Roche, Abbott, Thermo Fisher Scientific, Q

Yahoo Finance · 01/10/2026 · lire l'article ↗

Disposable Medical Sensors Market Forecasts Growth from $11.86B (2026) to $16.13B by 2031, Profiling Abbott, Roche, Medtronic & GE HealthCare

The global disposable medical device sensors market is projected to grow from USD 11.86 billion in 2026 to USD 16.13 billion by 2031, registering a 6.4% CAGR. Growth is driven by chronic and infectious diseases, remote patient monitoring, point-of-care diagnostics, wearable devices, home healthcare, and infection-prevention needs. Biosensors currently lead the market, while strip sensors are expected to gain the largest share. The US will record North America’s highest CAGR. Key players include

Yahoo Finance · 01/10/2026 · lire l'article ↗

Abbott launches Freenome’s colorectal cancer screening test

Abbott will sell Freenome’s SimpleScreen CRC test in the U.S. alongside the Cologuard Plus stool-based test it gained in the $21 billion acquisition of Exact Sciences.

Yahoo Finance · 30/09/2026 · lire l'article ↗